The QualityStocks Daily Wednesday, May 27th, 2020

Today's Top 3 Investment Newsletters

StocksToBuyNow (NTRR) +300.00%

StockMarketWatch (GRNQ) +212.46%

StreetInsider (HTZ) +136.04%

The QualityStocks Daily Stock List

BIOLASE, Inc. (BIOL)

Zacks, The Stock Market Watch, Stocks Herald, FX Empire, Market Chameleon, Stocktwits, Simply Wall St, Morningstar, Market Screener, Seeking Alpha, DBT News, Stockhouse, Investing.com, Barchart, Stockwatch, and StockNews reported earlier on BIOLASE, Inc. (BIOL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A medical device company, BIOLASE, Inc. is the worldwide leader in dental lasers. The Company manufactures and markets proprietary dental laser systems that enable dentists and dental specialists to perform a wide range of minimally invasive dental procedures. This includes cosmetic, restorative, as well as surgical applications. BIOLASE serves the General and Specialty Practices along with Group Practices. Established in 1984, BIOLASE is headquartered in Irvine, California.

The design of the Company’s laser systems are to provide clinically superior, patient-friendly results for many kinds of common dental procedures versus those achieved with traditional instruments. BIOLASE has sold more than 41,000 laser systems to date in more than 80 countries worldwide.

Waterlase is BIOLASE’s flagship product. Waterlase uses an innovative combination of water and laser energy to provide clinicians cool and efficient cutting of hard tissue, soft tissue, and bone. Waterlase’s patented all tissue technology is FDA (Food and Drug Administration) cleared for 80+ clinical indications. Waterlase safely debrides implants without damaging or significantly affecting surface temperature. Waterlase features same-day, multi-quadrant treatments. The result is fewer appointments for a patient.

BIOLASE has a full-spectrum portfolio of laser systems and procedural consumables. These include Waterlase Express™ - the smallest, easiest most cost-effective Waterlase; and Waterlase iPlus™ - the world’s best selling All-Tissue dental laser. Waterlase dental lasers use 80 percent less water versus traditional dental handpieces.

The laser can be used for numerous procedures. This includes cavity preparation, periodontal procedures, restorations, gingivectomies, frenectomies, and more. The Waterlase combines water, air, and laser energy for a more gentle experience. This limits the need for anesthetics and promotes faster healing times.

Products also include Epic Pro™ - a powerful and capable diode dental laser. In addition, products include Epic X™ - surgery, fast tooth whitening and pain therapy in one device.

Last month, BIOLASE announced that it expects to join the fight against the coronavirus (COVID-19) outbreak by teaming up with MEKICS Co. Ltd, an intensive care unit (ICU) equipment manufacturer, to supply MEKICS's MTV-1000 ICU-grade portable ventilator via BIOLASE's FDA-registered manufacturing facility in California. The MTV-1000 ventilator received FDA authorization for emergency use during the COVID-19 pandemic.

Mr. Todd Norbe, Chief Executive Officer of BIOLASE, said, "In this time of global crisis, it is vital that companies come together to support the fight against COVID-19, leveraging every tool available, and that's exactly what we intend to do. Without hesitation, we expect to pivot quickly and leverage our FDA-registered facility for the manufacturing and delivery of the MTV-1000 ventilator and have already received over $10 million in orders. We expect to continue to focus our efforts to quickly ramp up production, with the expectation to double the number of orders over the next few weeks."

BIOLASE, Inc. (BIOL), closed Wednesday's trading session at $0.4888, off by 2.8231%, on 1,106,500 volume with 2,076 trades. The average volume for the last 3 months is 2,876,695 and the stock's 52-week low/high is $0.210999995/$2.07259988.

chart

Body and Mind, Inc. (BMMJ)

InvestorsHub, Penny Stock Tweets, Insider Financial, PotStockNews, technical420, Investor Ideas, Market News Updates, MJ Global Report, Market Screener, New Cannabis Ventures, Midas Letter, Dividend Investor, Wallmine, Stockhouse, MicroSmallCap, Wallet Investor, GuruFocus, Trading View, StockTreats, Market Wire News, and Simply Wall St reported earlier on Body and Mind, Inc. (BMMJ), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Body and Mind, Inc. invests in high quality medical and recreational cannabis cultivation, production and retail. Its wholly-owned Nevada subsidiary was awarded one of the first medical marijuana cultivation licences. Furthermore, Body and Mind holds cultivation and production licenses. Body and Mind (BaM) products include dried flower, edibles, topicals, extracts, and GPEN Gio cartridges. Body and Mind is headquartered in Vancouver, British Columbia and lists on the OTCQB. Nevada Medical Group LLC (NMG Nevada) is a wholly-owned subsidiary of Body and Mind.

Body and Mind has collected, for many years’, elite cannabis plants from around the world. Through carefully crossbreeding these plants, it has developed strains that give what it states are the perfect balance of body and mind benefits. Its cannabis plants are grown with hands-on care in small batches. In addition, Body and Mind never uses synthetic pesticides. The Company offers an array of strains, available in flower, vapes, pre-rolls, and concentrates.

Body and Mind announced last year expansion into Arkansas with in-State partner, Comprehensive Care Group LLC (CCG). Medical marijuana dispensaries in Arkansas are licensed for retail sales and cultivation of up to 50 plants within the same facility.

Body and Mind has started manufacturing in California through the Body and Mind California subsidiary NMG Cathedral City (NMG). The Cathedral City facility has been producing THC (Tetrahydrocannabinol) distillate in bulk form since June of 2018. The facility is for manufacturing popular Body and Mind products. This includes oils, wax, live resin, ambrosia, as well as edibles. Body and Mind continues to expand operations in Nevada, California, Arkansas, and Ohio.

Recently, Body and Mind provided an update on operations starting at the Arkansas dispensary and closing of the San Diego ShowGrow transaction. BaM and Comprehensive Care Group, LLC opened the dispensary in West Memphis, Arkansas near the border with Tennessee. This was the 22nd dispensary to open in the State out of a total of 33 licensed dispensaries approved in Arkansas, and the first one in Zone 3 along the I-40 corridor.

Moreover, the Company has completed the transaction for the ShowGrow San Diego dispensary. The ShowGrow San Diego dispensary is owned and operated by NMG San Diego LLC, which is 60 percent owned by a BaM subsidiary.

Body and Mind, Inc. (BMMJ), closed Wednesday's trading session at $0.38, off by 2.1879%, on 48,665 volume with 33 trades. The average volume for the last 3 months is 97,574 and the stock's 52-week low/high is $0.150000005/$1.77999997.

chart
n

Graphite One, Inc. (GPHOF)

Stock Gumshoe, Beat Penny Stocks, Energy and Gold, TipRanks, GuruFocus, Simply Wall St, Mining News North, TradingView, Junior Mining Network, GlobeNewswire, Stock of the Week, Mining News Feed, InvestorIntel, Stockhouse, WallStreetAlerts.org, Make Penny Stocks Great Again, Investing News, Green Leaf Pot Stocks, Seeking Alpha, InvestorsHub, Wallet Investor, YCharts, and Proactive Investors reported earlier on Graphite One, Inc. (GPHOF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Graphite One, Inc. is exploring, with the intent to develop its Graphite One Project, where it could potentially become the dominant American producer of high grade Coated Spherical Graphite (CSG) that is integrated with a domestic graphite resource. The Project is proposed as a vertically integrated enterprise to mine, process and manufacture high grade graphite mainly for the electric vehicle lithium-ion battery market. The OTCQB-listed Company previously went by the name Graphite One Resources, Inc. It changed its name to Graphite One, Inc. in February of 2019. Established in 2006, Graphite One is headquartered in Vancouver, British Columbia.

According to Graphite One’s Preliminary Economic Assessment (PEA), potential graphite mineralization mined from its Graphite Creek Property is expected to be processed into concentrate at a graphite processing plant. The proposed processing plant would be situated on the Graphite Creek Property located on the Seward Peninsula approximately 60 kilometers north of Nome, Alaska.

CSG and other value-added graphite products would likely be manufactured from the concentrate at the Company's proposed graphite product manufacturing facility. Upon the completion of a Feasibility Study (FS), Graphite One intends to make a production decision. Graphite One (Alaska), Inc., is a wholly-owned subsidiary of the Company. It holds the Property and is developing the Project in Alaska.

This month, Graphite One announced that preliminary test work performed by the Company’s independent industrial partner (IPP) at an independent industrial laboratory using graphitic material from the Company's Graphite Creek project indicates potential additional products as a complement to Graphite One’s main focus on EV Batteries/Energy Storage Systems, including high-purity coatings, industrial synthetic diamonds, and fire retardant/fire suppressant foams. In addition, test work indicates that the non-graphite "impurities" in the graphitic material contain critical minerals that, like graphite itself, are on the U.S. Government Critical Minerals List.

Data generated from these tests are anticipated to inform the Graphite One pre-feasibility study (PFS), which, despite being slowed by the worldwide COVID-19 pandemic, is now expected to be released this Fall. No additional field work is required to complete the PFS.

Graphite One, Inc. (GPHOF), closed Wednesday's trading session at $0.507, up 11.9205%, on 103,697 volume with 80 trades. The average volume for the last 3 months is 44,083 and the stock's 52-week low/high is $0.093000002/$0.513999998.

chart

Guardion Health Sciences, Inc. (GHSI)

Market Chameleon, DBT news, GlobeNewswire, StockInvest.us, Stocktwits, Nasdaq News Feed, OTC Markets, Investors Observer, Street Insider, Stockhouse, Morningstar, TradingView, Stockopedia, last10k, Investing.com, Nasdaq, InvestorsHub, Investors Hangout, Barchart, Newsheater, Stock News, Simply Wall St, YCharts, The Winnex, MacroTrends, and Seeking Alpha reported beforehand on Guardion Health Sciences, Inc. (GHSI), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Guardion Health Sciences, Inc. is an ocular health sciences company listed on the NasdaqGS. It, among other things, develops, formulates, manufactures and distributes condition-specific medical foods supported by evidence-based protocols. The Company also provides ocular testing. Guardion Health Sciences’ initial medical food product, Lumega-Z, addresses a depleted macular protective pigment, a known risk factor for age-related macular degeneration (AMD) and a significant component of functional vision performance. The Company is at the vanguard of early detection, intervention and monitoring of numerous eye diseases. Guardion Health Sciences has its corporate office in San Diego, California.

Guardion has also developed a proprietary medical device, the MapcatSF®. It accurately measures the macular pigment density, therefore providing the only two-pronged evidence-based protocol for the treatment of a depleted macular protective pigment. The Mapcat is the most repeatable and accurate measuring technology for the MPOD (macular pigment optical density). Mapcat is protected by patents in the United States and Europe.

The aforementioned Lumega-Z is the only micronized lipid-base nutritional formulation designed to restore and maintain the condition of a depleted macular pigment. This unique delivery platform ensures the highest level of absorption as well as rapid patient response to treatment.

In addition, Guardion has its VectorVision. This is the most widely used and respected clinical contrast sensitivity test. Next generation VectorVision products have two patents protecting proprietary methodologies for the standardization of vision testing. Moreover, the Company has its GlaucoCetin as part of its portfolio. GlaucoCetin is the first regulated vision-specific Medical Food designed to support and protect the mitochondrial function of optic nerve cells in patients with glaucoma.

Guardion Health Sciences has developed an inventive proprietary formulation to provide immuno-support and anti-inflammatory benefits targeting the upper respiratory tract. Its efforts are being led by its recently acquired NutriGuard business line. NutriGuard formulates high-quality, scientifically-credible, condition-specific nutraceuticals designed to supplement consumers’ diets and assist in the prevention and management of an array of diseases and conditions.

In April, Guardion launched acuMMUNE. This is a proprietary immuno-supportive complex designed with the goal of supporting effective immune function.

This month, Guardion Health Sciences announced the publication of study data comparing the efficacy of the Company’s micronized liquid formula Lumega-Z®, to the current standard AREDS 2 soft gel supplement. Results from the study concluded that Guardion’s innovative, proprietary formulation, Lumega-Z, provided considerably higher blood concentration levels of carotenoids, which have been shown by studies sponsored by the National Eye Institute to be important for slowing the progression of macular degeneration in certain patients, and the MPOD, which has been shown in studies to be an important and modifiable biomarker to track the progression of macular degeneration and other eye diseases.

Guardion Health Sciences, Inc. (GHSI), closed Wednesday's trading session at $0.5019, off by 5.2661%, on 5,936,465 volume with 7,286 trades. The average volume for the last 3 months is 11,676,093 and the stock's 52-week low/high is $0.165000006/$3.04999995.

chart

Hallador Energy Company (HNRG)

Zacks, Stocktwits, DirectorsTalk Interviews, Equities.com, ETF.com, YCharts, Morningstar, Dividend Channel, Stockhouse, SmarterAnalyst, CSI Market, Investing.com, Stocknews, Annual Reports, Dividend.com, Macrotrends, Mining Feeds, ValueWalk, Market Screener, Stockopedia, PR Newswire, Barchart, Simply Wall St, and EarningsCast reported beforehand on Hallador Energy Company (HNRG), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Hallador Energy Company focuses on coal development and transportation delivery. Sunrise Coal, LLC is the Company’s main business unit. Sunrise has the capacity to produce 10 million tons of coal annually and has customers in the mid-west and southeastern United States. In addition, Hallador Energy owns Summit Terminal, a transport facility on the Ohio River. Hallador Energy is headquartered in Terre Haute, Indiana.

Sunrise Coal is Indiana’s 2nd largest coal producer. The Company concentrates on developing coal reserves in the Illinois Basin for the electric power generation industry. Current assets of Sunrise Coal include a 230MM ton complex of high-quality bituminous, low-chlorine coal located along the Indiana-Illinois boarder: Carlisle Mine (65MM tons), Oaktown 1 (65MM tons), and Oaktown 2 (100MM tons). Current assets also include Bulldog Reserve, Vermilion County, Illinois (55MM tons); and Ace in the Hole Mine (3.5MM tons).

This month, Hallador Energy Company reported a Net Loss of $3.7 Million, ($0.12) Per Share. Net Income was reduced $3.9 million by non-cash adjustments (interest rate swap and fuel hedge) in Q1. Impacts of delayed shipments and the permanent closure costs of the Carlisle Mine contributed to increased operating costs per ton of $2.43/ton over Q1 2019.

Mr. Brent Bilsland, President and Chief Executive Officer of Hallador Energy, stated, "Thermal export prices collapsed in the 2nd half of 2019, pressuring domestic steam coal pricing. Natural gas prices marked their lowest levels in 21 years during Q1 2020. Additionally, most of the United States and developed world closed and sheltered in place for 8-10 weeks during part of the 1st and 2nd quarter. The culmination of these extreme events led us to take proactive steps to plan for the future of Hallador's customers, investors and employees. Our actions are designed to increase our financial abilities so that we can ensure consistency at a time when the world is experiencing great volatility."

Hallador Energy Company (HNRG), closed Wednesday's trading session at $0.7338, up 6.1632%, on 178,513 volume with 749 trades. The average volume for the last 3 months is 218,083 and the stock's 52-week low/high is $0.606000006/$5.90000009.

chart

Indus Holdings, Inc. (INDXF)

BioPortfolio, New Cannabis Ventures, TeleTrader, OTC.Watch, Investing.com, Guerilla Stock Trading, Penny Stock Hub, InvestorX, Market Wire News, Business Insider, Investors Observer, Green Market Report, BioSpace, Stockwatch, NIC Investors, OTC Markets, Wallet Investor, Morningstar, Wallmine, TradingView, and Stockhouse reported previously on Indus Holdings, Inc. (INDXF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Indus Holdings, Inc. is a vertically integrated cannabis company listed on the OTCQX® Best Market. It has advanced production capabilities, including cultivation, extraction, manufacturing, brand sales, marketing, and distribution. The Company offers services supporting every step of the supply chain and it has an extensive portfolio of award-winning brands. Its distribution network touches 600+ dispensaries. Established in 2014, Indus Holdings is based in Salinas, California.

Indus’ brands include Cypress Cannabis, House Weed, The Original Pot Co., MOON, Acme, and Kaizen Medicinals. Indus Distribution is a division of Indus Holdings, Inc. Indus Distribution is a foremost distributor of cannabis products, servicing a broad portfolio of brands and licensed retailers. Indus Distribution operates two distribution centers. One is in southern California and the other is in northern California.

Regarding Extraction, Indus Holdings’ extraction facilities are licensed for adult use and medicinal cannabis production. They are located within a 5,000 square foot laboratory at the Company’s Salinas manufacturing facility.

Pertaining to Cultivation, the Company’s licensed cultivation operations are located within the Company’s 225,000 square foot greenhouse structure located on 10 acres near its headquarters in Salinas. The greenhouse offers full control of the growing environment, including temperature, water, humidity, light depravation, air pressure and more while being able to leverage the power of the sun in the spirit of sustainability.

Concerning Manufacturing, Indus’ manufacturing operation is operated by Cypress Manufacturing Company. Indus produces a broad array of cannabis-infused products in its 10,000 square foot manufacturing facility in Salinas. Its products include chocolate confections, beverages, baked goods, gummies, as well as hard candies.

Indus Holdings will release its financial results for Q1 2020 (ended March 31, 2020) after the market closes on Thursday, May 28th. The Company will host a conference call with management on Friday, May 29th at 8:30 a.m. EDT, in which they will address these recent financial and operational results.

Indus Holdings, Inc. (INDXF), closed Wednesday's trading session at $0.63, up 1.1236%, on 117,091 volume with 86 trades. The average volume for the last 3 months is 46,715 and the stock's 52-week low/high is $0.157000005/$7.84549999.

chart

Key Energy Services, Inc. (KEGX)

Zacks, OTC Markets, MarketBeat, RiggerTalk, Morningstar, OilandGas360, Nasdaq, Stockhouse, Dividend.com, MacroTrends, Annual Reports, Market Screener, Dividend Investor, Street Insider, InvestorsHub, EODData, MarketWatch, Stockopedia, Stockrow, and AI Stock Finder reported previously on Key Energy Services, Inc. (KEGX), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Key Energy Services, Inc. operates as an onshore rig-based well servicing contractor in the USA. It provides a wide array of unique energy production solutions and services. Key Energy Services enables America’s E&P companies, from small independents to majors, to get the most out of the life of their wells. Established in 1977, the Company is based in Houston, Texas.

Key Energy Services has pioneering, patented technology that can be used to help reduce non-productive time, decrease its customers’ lease operating expense (LOE), and total cost of ownership (TCO). The Company’s solutions include Well Completions, Water Management, Well Servicing, Rental Services, Well Intervention, and Cementing & Abandonment.

Regarding Key Rental Services, Key maintains a complete fleet of tools and expert personnel to serve clients’ needs. Its wide variety of rental equipment and services include tubular handling systems, drill pipe, work string and tubulars, pumps, Sand-X systems, Blowout preventers and accumulators. The Company also has a broad spectrum of fishing rental equipment used with Key’s Well Intervention Fishing Services.

Concerning Key Well Completions, the Company has the flexibility to provide a fit for purpose Well Service Rig or Coil Tubing Unit. Key Water Management has service locations in major basins across the continental United States. It offers premier service and support to meet the industry demands for fluid transport, storage, and disposal.

Key's Well Servicing solutions provide the largest and most diverse AESC Classification rig fleet and also the largest 1-1/4” to 2 -5/8” Coil Tubing fleet in the United States. Its comprehensive maintenance program eliminates over the hole exposure and reduces non-productive time.

Key Cementing and Abandonment solutions include the equipment and skill required to ensure that a client’s squeeze work, plug jobs, or surface casing cementing operations are executed impeccably to deliver a high integrity result. This is whether it be for a new well or a Plug & Abandonment operation. Key can also perform squeezes, pumping services, and all other forms of remedial cement applications.

Additionally, the Company has its Key Well Intervention solutions. These solutions provide the range of equipment and expertise to address clients’ needs. Its fleet of Class VI Double Drilling rigs are specifically suited to perform side tracks, re-entries, recompletions, and deep new well completions.

Earlier in May, Key Energy Services reported Q1 2020 Consolidated Revenues of $75.3 million and a Net Income of $109.0 million, or $26.66 per basic share versus Consolidated Revenues of $85.1 million and a Net Loss of $30.2 million, or $(73.62) per share for Q4 of 2019. Earnings per Share amounts for Q1 of 2020 include a gain of $170.6 million, or $41.7 per basic share, associated with Key’s exchange of term loan indebtedness for equity securities, and account for the 13.4 million shares issued in connection with the restructuring of the Company’s debt on March 6, 2020.

Key’s President and Chief Executive Officer, Mr. Marshall Dodson, stated, “We are pleased to have completed our previously announced restructuring in the first quarter. This restructuring has positioned Key with $25.6 million in cash as of the end of March and substantially reduced our debt and cash debt service needs with the ability to pay interest under the term loan in kind.”

Key Energy Services, Inc. (KEGX), closed Wednesday's trading session at $7.88, up 10.2098%, on 5,596 volume with 52 trades. The average volume for the last 3 months is 11,494 and the stock's 52-week low/high is $0.600000023/$177.50.

chart

Maverick Technology Solutions (MVRK)

Whale Wisdom, Penny Stock Hub, TipRanks, Biz Journals, GlobeNewswire, BioSpace, OTC Markets, News to Watch, OTC.Watch, Research Pool, Financial Buzz, Investors Hangout, wallstreet-online, Stockopedia, InvestorsHub, Stockhouse, Dividend Investor, Trading View, Cannabis Business Executive, Stockwatch, and Wallet Investor reported earlier on Maverick Technology Solutions (MVRK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Maverick Technology Solutions is the manufacturer of the highly acclaimed ROSINBOMB™ line of extraction presses and technology. The Company has more than three years operating history developing and producing the ROSINBOMB™ line of rosin presses and accessories for extracting organic concentrates. ROSINBOMB presses require no chemicals or additional hardware to operate. Maverick Technology Solutions is headquartered in Phoenix, Arizona and the Company lists on the OTC Markets.

ROSINBOMB presses are plug and play out of the box. This technology uses granted patent and patent pending techniques to optimize extraction processes and permit the user the ability to easily produce naturally-extracted, organic concentrates. ROSINBOMB presses are manufactured to be the premier quality presses available today. Maverick’s stainless steel, fully electric and patent-pending technology delivers 5,000+ lbs of pressure. The design is to ensure the highest possible yield.

Maverick Technology Solutions’ extraction presses and related accessories, most notably the ROSINBOMB Rocket, have been met with critical acclaim. The year 2018 saw the Rocket being named a Top 10 product by Forbes, the “Best Portable Rosin Press” by Herb, and one of the “Top Holiday Gifts Over $200” by Leafly.

Maverick Technology Solutions launched in 2019 its production-grade press, the M-60 with Patent Pending Flow Channel Technology™. The M-60 is a significant leap forward in solventless press technology. It is the third in a series of industry leading extraction presses from ROSINBOMB. The M-60 technology enables processors to quickly and easily produce large volumes of solventless, clean, organic extracts solely utilizing heat and force.

In December 2019, Maverick Technology Solutions announced another industry first, the ROSINBOMB Conversion Plate. Engineered for the M-60 production-grade press and made of aircraft-grade aluminum, the Company states that the Conversion Plate makes the M-60 the most complete production press on the market. The launch in 2019 of the ROSINBOMB M-60 with Patent Pending Flow Channel Technology™ set a new precedent in extraction press technology making it the first ever solvent free press for large-scale, continuous concentrate production.

The addition of the ROSINBOMB Conversion Plate™ easily and rapidly transforms the M-60 into a traditional single action press for those times when processors need to run a sample or test batch or want to press a small amount of material. This makes it the first and only press of its type to offer this dual processing capability.

Recently, Maverick Technology Solutions announced that Forbes.com has written an in-depth feature and interview with the Company’s President, Mr. Ryan Mayer, and Chief Executive Officer, Mr. Fred Angelopoulos. Forbes contributor Mr. Warren Bobrow asked a series of probing questions about the ROSINBOMB brand, products and vision for Maverick Technology Solutions’ future. Mr. Mayer and Mr. Angelopoulos provide insight into the origins of the Company and their beliefs and passion to continually innovate the brand and products and push through all barriers on their mission to help the consumer and the commercial developers craft safe, solventless and organic extracts.

Maverick Technology Solutions (MVRK), closed Wednesday's trading session at $0.30, up 50.00%, on 4,350 volume with 8 trades. The average volume for the last 3 months is 12,351 and the stock's 52-week low/high is $0.012/$2.00.

chart

POSaBIT Systems Corporation (POSAF)

High Green News, Stockhouse, 1StopTrading, TipRanks, Nasdaq, Invest.com, Simply Wall St, Business Wire, Morningstar, Dividend Investor, Investing News, Wallet Investor, TradingView, GuruFocus, Newsfilecorp, MarketWatch, and Seeking Alpha reported beforehand on POSaBIT Systems Corporation (POSAF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

POSaBIT Systems Corporation is a financial technology company listed on the OTC Markets. It provides unique, advanced, fully-integrated, point of sale (POS) for retailers and dispensaries. The Company provides a total solution for cash-only businesses, such as those within the cannabis industry. POSaBIT Systems has its corporate headquarters in Kirkland, Washington.

The Company provides blockchain-enabled payment processing and POS systems for cash-only businesses, with a special emphasis on the above-mentioned cannabis industry. It specializes in resolving problems for complex, high-risk, developing industries. like cannabis. with an all-in-one solution that is compliant, user-friendly and uses premier hardware.

Software features of POSaBIT Systems’ POS offering include Integrated Online Ordering, Customer Profile & Favorites, Integrated Loyalty, Customer Purchase History, Custom Discounts, Debit Payments, and Product Details. The robust management console allows a user to control their whole business from any location. Hardware features of the POS offering include a Built-in Printer, a Built-in Cash Drawer, and a Swivel Screen.

The Company’s online gateway gives one access to real-time reporting of store performance, customer demographics, as well as transaction data. POSaBIT Systems has incorporated third-party software into its POS system. This means one fewer system to check and update on a daily basis. Moreover, the Company is the only fully-compliant provider of debit payments for cannabis retailers. Debit payments are built into its POS system as part of its blockchain solution. Each month, POSaBIT Systems processes millions of dollars of transactions for merchants across the USA.

Recently, POSaBIT Systems announced it has brought its full POS solution to the State of Montana. The Company successfully integrated its POS with Montana’s METRC seed-to-sale requirements. POSaBIT has made its solutions available to all Montana medical marijuana dispensaries.

The Montana cannabis market is set to expand its potential with new legislation taking effect this year, which will permit medical marijuana patients to be “untethered” from their previously assigned dispensaries. This will effectively open up the market to more competition and sales among Montana’s 350 medical dispensaries.

POSaBIT Systems Corporation (POSAF), closed Wednesday's trading session at $0.15, up 334.7826%, on 165 volume with 1 trade. The average volume for the last 3 months is 7,155 and the stock's 52-week low/high is $0.009999999/$0.306800007.

chart

Regen BioPharma, Inc. (RGBP)

Small Cap Solutions, InvestorTrendz, Insider Financial, TopPennyStockMovers, YCharts, ProTrader, Emerging Growth, SmallCapVoice, Wall Street Mover, TheMicrocapNews, and The OTC Reporter reported earlier on Regen BioPharma, Inc. (RGBP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Regen BioPharma, Inc. is a biotechnology company listed on the OTC Markets’ OTCQB. The Company works to identify undervalued regenerative medicine applications in the immunotherapy and stem cell space. Its aim is to quickly advance these technologies through pre-clinical and Phase I/II clinical trials.  Checkpoint Immunology, Inc. is a wholly-owned subsidiary of the Company. Regen BioPharma has its head office in La Mesa, California.

At present, Regen BioPharma is focusing on checkpoint inhibitor and gene silencing therapies for treating cancer. Furthermore, it is focusing  on developing stem cell treatments for aplastic anemia. Fundamentally, the Company is working to increase the quality of life through therapies involving small molecules, stem cell treatments, and the body's own immune system.  It is currently developing products treating blood disorders employing small molecules and gene silencing (DiffronC) and treating cancer with immunotherapy (dCellVax). 

Regen BioPharma is also modulating vital molecular processes in cancer stem cells by way of its patented molecular targeting approaches (BORIS). In addition, it is repairing damaged bone marrow in patients with aplastic anemia and chemotherapy/radiotherapy treated cancer patients (HemaXellerate). 

Regen BioPharma is centering on small molecules to activate and inhibit its main target of interest, NR2F6. The Company is continuing to develop the NR2F6 program in-house before entering into any potential partnerships. It has granted CheckPoint Immunology an exclusive international license to develop and commercialize Regen's NR2F6 technology for human therapeutic use. The objective of the license grant is the separation of Regen BioPharma’s small molecule technology from its other Intellectual Property (IP) to facilitate any future transactions involving small molecule therapies focused on the NR2F6 checkpoint.

In September, Regen BioPharma reported that its researchers identified a series of small molecule drugs, which inhibit NR2F6 as well as activate human immune cells ex-vivo. Evidence provided by studies suggest that NR2F6 represses the body's immune response against tumors. Therefore, inhibiting NR2F6 may lead to enhanced immune response against cancerous tumor cells.

Harry Lander, Ph.D., MBA, President and Chief Scientific Officer of Regen BioPharma, said, "Based on the known activities of NR2F6, we expect that inhibiting its activity will lead to increased T cell activation. We found that several of our NR2F6 antagonists can activate human immune cells, such as T cells, leading to increased IL-17a production in a concentration-dependent manner."

Recently, Regen BioPharma reported that its researchers determined that its lead NR2F6 small molecule agonist, RG-NAH005, is now ready for testing in animal models of inflammatory bowel disease (IBD). Regen will pursue this testing as a joint venture (JV) with Zander Therapeutics, Inc. Zander Therapeutics has been granted an exclusive license by Regen to develop and commercialize the Company's NR2F6 IP for veterinary applications.

Regen BioPharma, Inc. (RGBP), closed Wednesday's trading session at $0.0002, up 100.00%, on 2,001,184 volume with 4 trades. The average volume for the last 3 months is 3,333,802 and the stock's 52-week low/high is $0.000000999/$0.002899999.

chart

Cerebain Biotech Corp. (CBBT)

Greenbackers,  Viral Stocks, and Wall Street Mover reported on Cerebain Biotech Corp. (CBBT), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Cerebain Biotech Corp. centers on the creation and clinical development of a minimally invasive implantable device and a synthetic drug solution. A development-stage medical device enterprise,  the Company formerly went by the name Discount Dental Materials, Inc. It changed its corporate name to Cerebain Biotech Corp. in June 2014.

Cerebain Biotech lists on the OTC Markets’ OTCQB. The Company is based in Costa Mesa, California. 

Cerebain Biotech’s technology has allowed for the development of a medical device that can be implanted using a minimally invasive procedure. Upon  implantation, through what will most likely be a same-day surgery procedure, patients may not have to undergo surgery again using this treatment method. 

Cerebain’s device leverages the clinically observable, positive impact that omentum stimulation has on cognitive function as related to dementias, and in particular, Alzheimer’s disease. The Company’s  patent-pending device is implanted in the omentum.  The omentum is a protective layer of skin that protects the abdominal organs.

The design of the device is to stimulate the omentum in patients with Alzheimer’s disease. Omental stimulation has been shown to improve cognitive function in patients with dementias,  including  Alzheimer’s disease. 

Cerebain Biotech will evaluate the effect of omental stimulation at different intervals and levels of stimulation to measure the device’s ability to slow, stop or reverse the progression of Alzheimer’s disease on patients. The Company’s novel device approach is supported by research and patient outcomes.

Cerebain Biotech has signed a Memorandum of Understanding  (MOU) with the Department of Neurodegenerative Diseases, Mossakowski Medical Research Centre in Poland. The purpose of the MOU is to commence testing of Cerebain’s Medical Device upon completion of development. Moreover, Cerebain has a manufacturing agreement with Sonos Medical, a medical device supplier.

At the beginning of March, Cerebain Biotech announced that its intention is to begin the search process to partner with a Contract Research Organization (CRO). The search comes as the Company prepares for clinical trials and the FDA application process in combination with the development and testing of its medical device for the treatment of Alzheimer’s and Dementia. Furthermore, in March, Cerebain announced that its strategic partner, Sonos, added key personnel to its staff to facilitate the acceleration in development of the company’s medical device.

Cerebain Biotech Corp. (CBBT), closed Wednesday's trading session at $0.0008, up 60.00%, on 26,906,436 volume with 51 trades. The average volume for the last 3 months is 6,277,798 and the stock's 52-week low/high is $0.000199999/$0.0027.

chart

Advanced BioMedical Technologies, Inc. (ABMT)

Zacks, Stockrow, and 4-Traders reported on Advanced BioMedical Technologies, Inc. (ABMT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Advanced BioMedical Technologies, Inc. manufactures and distributes advanced impedance controlled micro-current instruments.  The Company has treated more than 15,000 patients during the past 28 years. It is a leader in education, research, training, and instrument sales and works with doctors and clinicians throughout the U.S. This includes those in Minnesota, the majority of which have an affiliation with the University of Minnesota. Advanced BioMedical Technologies is based in Eagan,  Minnesota.

The Company is the oldest distributor of the Electro-Acuscope and Electro-Myopulse. Advanced BioMedical has a 6,000-square foot office complex, with 3,000 square feet dedicated as a patient care treatment center.

The Electro-Acuscope and Electro-Myopulse instruments feature the most sophisticated computerized, feedback-controlled, energy delivery, micro-current technology available today. Acuscope products include the Electro-Acuscope 85P (Portable); the Electro-Acuscope 80L; and the Neuroscope 230B. Myopulse products include the Electro-Myopulse 75L (Base Model) and the Electro-Myopulse 75F (used in Fermi Lab Study).

The Electro-Myopulse measures the Bio-Impedance of the muscle tissue between the two electrodes. Similarly, this is how the current amplitude and voltage output is adjusted and controlled. The Myopulse uses a sine wave. This sine wave imitates the wave produced when a muscle first contracts.

The Electro-Acuscope monitors nerve conduction between two electrodes. This is how the current amplitude and voltage output is adjusted and controlled. The Acuscope uses a complex waveform. This waveform imitates a nerve impulse.

The Neuroscope 230B (Home Care Unit) is for the personal treatment of sleep, anxiety,  and pain issues. The product is a personal treatment device for the person on the go. Moreover, it is as an adjunct to Acuscope and Myopulse (impedance controlled microcurrent) therapy where extended rehabilitation therapy  require  more treatments at home.  

The design of the Electro-Acuscope 85P (Portable)  instrument is for the traveling clinician or patient (with prescription). This instrument is built into a haliburtor case for safe and easy portability.

Furthermore, Advanced BioMedical Technologies has its La Fleur products. These include the Electro-Myopulse 75LN Premium Instrument (Myopulse, Facial and Esthetics), which was developed exclusively by the Company. In addition, the Company carries a line of Accessories.

Recently, Advanced Biomedical Technologies announced that the State Intellectual Property Office of The People’s Republic of China (SIPO) issued the Company a new patent titled “Bone Fracture Plate Made of High Polymer Materials”.

Its subsidiary Shenzhen Changhua Biomedical Engineering Company Limited is entitled for the new patent (ZL 2014 1 0647464.1), which strengthens the Company's position in manufacturing process and related controls using its innovative polyamide materials (PA).

Advanced BioMedical Technologies, Inc. (ABMT), closed Wednesday's trading session at $0.49, up 186.5497%, on 3,498 volume with 4 trades. The average volume for the last 3 months is 1,459 and the stock's 52-week low/high is $0.012/$0.50999999.

chart

Tautachrome, Inc. (TTCM)

MarketWatch and InvestorsHub reported on Tautachrome, Inc. (TTCM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Tautachrome, Inc. is an emerging growth enterprise in the developing digital imagery technology sector. It is a developer of software applications for trustable and engageable digital pictures and videos. The Company’s chief priority is developing its branded KlickZie platform. An Internet technology development business, Tautachrome is headquartered in Oro Valley, Arizona and has operations in the United States and Australia.

The KlickZie platform will turn smartphones into trusted imagers. This means the pictures and videos they capture can be verified as original, untampered,  and un-photoshopped. Additionally, the KlickZie platform creates imagery that is interactive and engageable.

The KlickZie platform will serve as the world’s first imagery-based social website network. Through clicking or tapping on a KlickZie'd image, users can communicate with the image's author or others presently looking at the image, in an engaging way.

Basically,  KlickZie is an image verification service for smartphones. It brings trust back to digital imagery. In addition, KlickZie turns the smartphone into a reliable image source. Smartphone users download KlickZie’s free software to take their pictures and videos.

KlickZie pictures and videos are invisibly marked, stored in the KlickZie cloud, and guaranteed free from manipulation. The cloud will certify the authenticity of any KlickZie picture or video.

Tautachrome also has pioneering patents pending. These include Talk-to-the-Picture social networking and the abovementioned trustable imagery-based interaction.

Tautachrome is establishing a development team of providers to develop a blockchain based cryptocurrency ecosystem with a cryptotoken designated “KLK”. It will be the currency of the KlickZie community internationally.

This will permit KlickZie users to monetize their pictures and videos. As a result, it will enable the buying, selling, and licensing of KlickZie pictures and videos everywhere.

Recently, Tautachrome announced that it hired the Pryor Cashman law firm in New York to lead its work to register its KLK cryptotoken sale with the Securities and Exchange Commission (SEC). Mr. Ali Panjwani with support from his colleagues Mr. Jeff Alberts and Mr. Mike Campoli is leading the Pryor Cashman work team.

This team has considerable cryptotoken knowledge. In addition, it has significant experience with SEC registration. This includes past employment with the SEC in this area.

Tautachrome Chief Executive Officer, Dr. Jon N Leonard, said, “I have directed the Pryor Cashman team to work with the SEC’s crypto currency task force to ensure that our vision for a KLK cryptotoken-based ecosystem, able to monetize the world’s smartphone imagery becomes a reality, and that it is fully compliant with SEC regulations. We appear to be breaking new ground in this work. But I believe that the social and economic potential of this effort is so great, that every effort is justified.”

Tautachrome, Inc. (TTCM), closed Wednesday's trading session at $0.00651, up 71.3158%, on 77,157,613 volume with 809 trades. The average volume for the last 3 months is 11,200,438 and the stock's 52-week low/high is $0.0019/$0.032900001.

chart

Wizard World, Inc. (WIZD)

Wall Street Resources and TopPennyStockMovers reported earlier on Wizard World, Inc. (WIZD), and we report on the Company as well, here at the QualityStocks Daily Newsletter. 

Wizard World, Inc. is the foremost provider of multiple Comic Cons and pop culture conventions around the world. The Company produces Comic Cons (live multimedia conventions) and pop culture conventions. These celebrate pop-fi, pop culture, movies, television, cosplay, comics, graphic novels, toys, video gaming, sci-fi, gaming, original art, collectibles, contests and more. Wizard World has its headquarters in El Segundo, California. The Company’s shares trade on the OTC Bulletin Board (OTC BB).

Wizard World’s events frequently feature celebrities from movies and TV, artists and writers, and events such as premieres, gaming tournaments, panels, as well as costume contests.  The Company has its ComicConBox™. This is a subscription-based premium monthly box service. It provides fans the opportunity to receive exclusive collectibles, toys, technology, games, licensed artwork, comics, apparel, Wizard World Comic Con tickets, VIP discounts and more, delivered to their doors. 

The Company’s Comic Cons provide sales, marketing, promotions, public relations, advertising, and sponsorship opportunities for entertainment companies, toy companies, gaming companies, publishing companies, marketers, corporate sponsors, and retailers.

Wizard World Digital is the Company’s online publication. It covers new and upcoming products and talents in the pop culture world. Also, Wizard World has established a new SocialCon™ Operating Unit within Wizard World. SocialCon™ will produce a series of conventions. These will feature meet-and-greets, live performances, Q&A panels, autographs, photo opportunities and more with many of today’s most-followed social media influencers.

In addition, Wizard World has its CONtv. This is a subscription-based digital service. It brings fans their favorite films, TV series, comics, behind the scenes access to Wizard World Comic Cons, and more.

CONtv provides consumers access to thousands of hours of exclusive content highlighting an original slate of programming and a comprehensive digital catalog of over 1,200 titles. Furthermore, Wizard World has launched the new music concert series, and the Wizard World Store. 

In September 2017, Wizard World announced its partnership with CNLive to distribute streamed content in the People's Republic of China (PRC). This partnership with CNLive, one of only seven entities licensed to distribute content over the internet in the PRC, provides Wizard World China, a wholly-owned subsidiary of Wizard World, a multi-year right and license to program a 24/7, advertising supported channel throughout all of mainland China. This includes Macao and Hong Kong.

Wizard World, Inc. (WIZD), closed Wednesday's trading session at $1.00, up 92.3077%, on 2,679 volume with 10 trades. The average volume for the last 3 months is 1,003 and the stock's 52-week low/high is $0.174099996/$5.80000019.

chart

The QualityStocks Company Corner

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR)

The QualityStocks Daily Newsletter would like to spotlight Energy Fuels Inc. (UUUU).

Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR), the leading uranium producer in the United States, announces the results of the election of directors and other matters at its annual meeting of shareholders (the "Meeting") held virtually on May 27, 2020.

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR), based in Lakewood, Colorado, is the country’s largest producer of uranium and the leading conventional producer of vanadium, both designated by the U.S. government as critical minerals.

As the leading U.S. diversified uranium miner, Energy Fuels’ uranium production portfolio stands apart in the world. Energy Fuels has more uranium production facilities, more production capacity, and more in-ground resources than any other company in the United States. In fact, the company’s assets have produced over one-third of all U.S. uranium over the past 15 years and is uniquely positioned to increase production to meet new demand.

Energy Fuels utilizes both conventional and in-situ recovery (“ISR”) technology to produce uranium from three strategic facilities:

  • White Mesa Mill in Utah (conventional) has a licensed capacity of over 8 million pounds of U3O8 per year. The highly strategic White Mesa Mill is the only conventional uranium mill in the country and is proximate to some of the largest and highest-grade uranium mines and projects in the U.S., including the Company’s Canyon mine, La Sal Complex, Henry Mountains Complex and Roca Honda Project. White Mesa Mill provides Energy Fuels with significant production scalability as uranium demand increases. The White Mesa Mill also has other diverse businesses, including vanadium, rare earth elements (REE’s), alternate feed materials recycling and land cleanup, all described below.
  • Nichols Ranch Plant (ISR) is located in the productive Powder River Basin district of Wyoming and has a total licensed capacity of 2 million pounds of U3O8 per year. Nichols Ranch has produced 1.2 million pounds of U3O8 since commissioning in 2014, and it has significant future expansion potential from 34 fully licensed wellfields containing significant in-ground uranium resources.
  • Alta Mesa Plant (ISR) is located on over 200,000 acres of private land in Texas. The fully licensed and constructed ISR project has a total operating capacity of 1.5 million pounds of uranium per year and produced nearly 5 million pounds of U3O8 between 2005 and 2013. This low-cost production facility is currently on standby, maintained in a state of readiness to respond to expected increases in demand.

In addition to being the largest uranium miner in the U.S., Energy Fuels’ overall portfolio also includes a pipeline of high-quality, large-scale exploration and development projects that are permitted or are in advanced stages of permitting, as well as an industry-leading U.S. NI 43-101 Mineral Resource portfolio.

FACTOID: Energy Fuels has led industry efforts over the past two-plus years to get the U.S. government to recognize the importance of domestically produced uranium, including the 2018 – 2019 Uranium Section 232, the ongoing Nuclear Fuel Working Group and the recently announced creation of the U.S. strategic uranium reserve. The U.S. is by far the largest consumer of uranium in the world, yet we import almost all of our requirements; Energy Fuels aims to change that.

Nuclear Market Potential

Multiple studies in top scientific journals have shown that nuclear power is cleanest and most economical way to produce reliable electricity as worldwide demand continues to soar. Nuclear power is presently the only available and affordable low-carbon power source that can meet both current and future baseload electricity demands while simultaneously reducing air pollution and mitigating climate change. U.S. nuclear power plants currently generate nearly 20% of the nation’s electricity overall and 55% of its carbon-free electricity and even a modest increase in electricity demand would require significant new nuclear capacity by 2025. According to the World Nuclear Association (WNA), there are currently 441 operable reactors, with another 54 units under construction and 439 in various stages of planning; in addition, the WNA has identified a potentially massive supply/demand gap through 2040 of 1 billion pounds. These factors among others are expected to significantly drive increased demand for uranium.

Reasons Nuclear is Gaining Traction

  • Nuclear reactors emit no greenhouse gases during operation. Over their full lifetimes, they result in comparable emissions to renewable forms of energy such as wind and solar.
  • Unlike any other form of energy, the waste from nuclear energy is contained and managed securely. Used fuel is currently being safely stored for ultimate disposal or future reprocessing, and 96% of this waste can potentially be recycled.
  • Greater demand for clean electricity to power everything from homes to automobiles, reducing dependence on fossil fuels.

No. 1 U.S. Producer of Vanadium in 2019

Energy Fuels also produces vanadium as a byproduct of uranium production. Vanadium is designated a critical mineral, essential to the economic and national security of the United States. Energy Fuels was the largest producer of vanadium in the U.S. in 2019, and has significant high-grade, in-ground vanadium resources, as well as a separate high-purity vanadium production circuit at their White Mesa Mill, which is also the only conventional vanadium mill in the country. Crucial for use in the steel, aerospace, and chemical industries, vanadium plays a critical role in the production of high-strength and light-weight metallic alloys and demand is expected to increase across the globe.

Energy Fuels has several fully permitted and developed standby mines containing large quantities of high-grade vanadium, along with uranium, including:

  • La Sal Complex (Utah)
  • Whirlwind Mine (Colorado/Utah)
  • Rim Mine (Colorado)

Vanadium has also gained increased attention as a catalyst in next-generation high-capacity, “community-scale” batteries used for energy storage generated from renewable sources. Demand is only expected to grow as this market expands. With recent upgrades in its vanadium production operations, in 2019 Energy Fuels produced commercial levels of the highest purity (99.7%) vanadium in the mill’s history and can rapidly adjust production to meet volatile market conditions. Energy Fuels is one of the very few known avenues that provides investors access the vanadium market.

Rare Earth Element (REE) Production, Alternate Feed Material Recycling, and Land Cleanup

The White Mesa Mill also provides the company with diverse cashflow generating opportunities. Security of supply for Rare Earth Elements (REEs) supporting U.S. military and defense requirements is a major issue today. Energy Fuels has been approached by a number of entities, including the U.S. government, inquiring about the potential to process certain REEs at the mill. The White Mesa Mill is currently licensed to process certain REEs, including tantalum and niobium. And, early indications are that the mill can be utilized to produce several other REEs. The White Mesa Mill is also the only facility in North America licensed and capable of recycling alternate feed materials (AFMs). AFMs are essentially low-level waste materials that contain recoverable quantities of natural (or unenriched) uranium. The Company typically generates between $5 and $15 million per year from AFM recycling. Finally, Energy Fuels is seeking to become involved in the cleanup of legacy Cold War era uranium mines in the Four Corners region of the U.S., including on the Navajo Nation. The U.S. Environmental Protection Agency (EPA) has access to over $1.5 billion for the cleanup of just a fraction of the sites on the Navajo Nation. The White Mesa Mill is fully licensed to receive much of this material, we are one of the government’s lowest cost options, and we have the ability to recycle the material and produce usable uranium from it.

Management Team

Mark S. Chalmers, President and CEO
Mark S. Chalmers is the president and chief executive officer of Energy Fuels, a position he has held since Feb. 1, 2018, following his role as chief operating officer of Energy Fuels from July 1, 2016 – Jan. 31, 2018. From 2011 to 2015, Chalmers served as executive general manager of Production for Paladin Energy Ltd., a uranium producer with assets in Australia and Africa, including the Langer Heinrich and Kayelekera mines where, as head of operations, he oversaw sustained, significant increases in production while reducing operating costs. He also possesses extensive experience in in situ recovery (“ISR”) uranium production, including management of the Beverley Uranium Mine owned by General Atomics (Australia), and the Highland mine owned by Cameco Corporation (USA). Chalmers has also consulted to several of the largest players in the uranium supply sector, including BHP Billiton, Rio Tinto, and Marubeni, and until recently served as the chair of the Australian Uranium Council, a position he held for 10 years. Chalmers is a registered professional engineer and holds a Bachelor of Science in Mining Engineering from the University of Arizona.

W. Paul Goranson, COO
W. Paul Goranson is the chief operating officer for Energy Fuels. Goranson has 30 years of mining, processing and regulatory experience in the uranium extraction industry that includes both conventional and in-situ recovery (“ISR”) mining, and he is a registered professional engineer. Prior to the acquisition by Energy Fuels of Uranerz Energy Corporation, Goranson served as president, chief operating officer and director for Uranerz, where he was responsible for operations of the Nichols Ranch ISR Uranium Project. In addition to those duties, he also managed uranium marketing, regulatory and government affairs, exploration and land. Prior to joining Uranerz, Goranson served as president of Cameco Resources, where he led the operations at the Smith Ranch-Highland, Crow Butte and North Butte ISR uranium recovery facilities. Goranson also served as vice president of Mesteña Uranium LLC, and he has served in senior positions with Rio Algom Mining, (a subsidiary of BHP Billiton), and Uranium Resource Inc. Goranson has a Bachelor of Science in Natural Gas Engineering from Texas A&I University, and a Master of Science in Environmental Engineering from Texas A&M University-Kingsville.

David C. Frydenlund, CFO, General Counsel, Corporate Secretary
David C. Frydenlund is chief financial officer, general counsel, and corporate secretary of Energy Fuels. His responsibilities include oversight of all legal matters relating to the company’s activities. His expertise extends to NRC, EPA, state and federal regulatory and environmental laws and regulations. From 1997 to 2012, Frydenlund was vice president of regulatory affairs, general counsel and corporate secretary of Denison Mines Corp., and its predecessor International Uranium Corporation (“IUC”). He also served as a director of IUC from 1997 to 2006 and CFO of IUC from 2000 to 2005. From 1996 to 1997, Frydenlund was vice president of the Lundin Group of international public mining and oil and gas companies, and prior thereto was a partner with the Vancouver law firm of Ladner Downs (now Borden Ladner Gervais) where his practice focused on corporate, securities and international mining transactions law. Frydenlund holds a bachelor’s degree in business and economics from Simon Fraser University, a master’s degree in economics and finance from the University of Chicago and a law degree from the University of Toronto.

Curtis H. Moore, Vice President of Marketing and Corporate Development
Curtis H. Moore is the vice president of Marketing and Corporate Development for Energy Fuels. He oversees product marketing for Energy Fuels, and is closely involved in mergers & acquisitions, investor relations, public relations, and corporate legal. He has been with Energy Fuels for over 12 years, holding various roles of increasing responsibility. Prior to joining Energy Fuels, Moore worked in multi-family real estate development, government relations and public affairs, production homebuilding, and private law practice. Moore is a licensed attorney in the State of Colorado. He holds Juris Doctor and MBA degrees from the University of Colorado at Boulder, and a Bachelor of Arts dual degree in Economics-Government from Claremont McKenna College in Claremont, California.

 

Energy Fuels Inc. (UUUU), closed Wednesday's trading session at $1.68, up 3.0675%, on 1,489,048 volume with 3,809 trades. The average volume for the last 3 months is 1,702,224 and the stock's 52-week low/high is $0.779999971/$3.31999993.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products (CSE: PLUS) (OTCQX: PLPRF) on Tuesday announced that, following market close on Thursday, May 28, the company will report its financial and operational results for the three months ended March 31, 2020. The company will also be hosting a conference call and webcast to discuss the financial results, as well as recent corporate highlights, on May 28 at 5:00 PM ET. At the end of the call, Plus Products co-founder and CEO Jake Heimark and CFO Jon Paul will be conducting a question and answer session. To view the full press release, visit http://cnw.fm/dD9zO

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Wednesday's trading session at $0.6745, up 7.0975%, on 36,803 volume with 43 trades. The average volume for the last 3 months is 41,450 and the stock's 52-week low/high is $0.279000014/$4.03999996.

Recent News

chart

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF)

The QualityStocks Daily Newsletter would like to spotlight Exro Technologies Inc. (OTCQB: EXROF).

Exro Technologies (CSE: XRO) (OTCQB: EXROF) is a clean-tech company committed to transforming energy conversion to enhance the performance, efficiency and longevity of electric motors. An article discussing the company reads, “‘With global warming becoming a severe issue, consumers have become aware of the need to embrace renewable energy programs directly and come to terms with more sustainable transportation options,’ stated a recent “Plug and Play” article (http://nnw.fm/nG7a9). To view the full article, visit http://nnw.fm/BtH5Y.

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), a Canadian technology company, is an innovative pioneer in the energy sector. Exro has developed and commercialized an electric power module (EPM) that integrates into existing motor systems to make them smarter. Exro’s patented technology optimizes existing motor performance by automatically sensing and adapting operating parameters to an optimized state, creating measurable efficiency gains, reduced mechanical components and increased system availability.

Applications

Exro’s technology and efficiency optimization algorithms improve the performance and efficiency of electric motors by manipulating power delivery to individual coils, thereby enabling the ability to expand operating parameters. This novel approach is scalable and can be utilized in most variable torque applications.

The widespread applications of Exro’s technology apply to optimizing the performance of electric vehicles, locomotive traction applications, industrial motors, and other variable torque applications that benefit from smart energy conversion.

Intellectual Property

Exro’s proprietary, patented software controls electric motor coils through individual coil switching. This introduction of intelligence into energy conversion at the level of individual coils results in expanded speed/torque capability, improved machine efficiency, reliability, safety and maintenance across a wider operating range. Exro’s advanced control algorithms create smart, real-time optimized power management.

Exro currently holds 15 patents, with 8 patents pending and additional patents under development. The company continues to expand its IP portfolio to support its goal of becoming a globally recognized leader in leveraging advanced control algorithms to improve the performance, efficiency and longevity of electric motors and generators.

Market Opportunity

Electric motors are the single biggest consumer of electricity. They account for about two-thirds of industrial power consumption and about 45% of global power consumption, according to an analysis by the International Energy Agency. Exro’s technology seeks to give industries a new way to look at energy—from electric vehicles, to industrial equipment, to renewable applications like wind farms; we are improving the way energy is consumed.

Laboratory Expansion

The 6,500-square-foot Exro Innovation Center (EIC), scheduled to open spring of 2020 in Calgary, will transition the current Victoria lab into one Calgary based center. The company’s new laboratory space will expand its service capabilities to customers, provide larger test capabilities, and showcase how Exro’s technology can be applied to dramatically improve the performance of electrical motors.

The EIC will also host collaborative events to explore advances in energy consumption and electric motor innovations, with participants from across Canada and around the world.

Strategic Partnerships

  • A strategic agreement with Finland’s Aurora Powertrains Oy, which in 2019 released an all-electric production snowmobile called the “eSled,” will see Exro’s technology added to the Aurora electric powertrain. The snowmobile sector’s economic footprint is estimated at $26 billion in the U.S., $8 billion in Canada, and $5 billion in Europe and Asia.
  • An agreement with Potencia in Mexico serving the last mile vehicle segment will integrate Exro’s custom drive and EPM module into small passenger commercial vehicles (taxis) and fleet delivery trucks
  • A licensing agreement with Motorino Electric, a leader in the Canadian electric transportation industry, will integrate Exro’s Electric Power Module technology into Motorino’s CTi electric bicycle.

Management

Chief Executive Officer Sue Ozdemir is a proven leader in the innovation and manufacturing of electric motors. She has nine years of accomplishments at General Electric, acting as CCO and the CEO of GE’s Small Industrial Motors Division, overseeing the division’s North American and international markets – ultimately building the division into a $160 million enterprise.

Chief Commercial Officer Josh Sobil is leading the seamless adoption of Exro’s growing product portfolio focused on the mobility segment and opening doors in all segments including agriculture, heavy industry, energy, construction, among others.

Executive Chairman Mark Godsy is a serial technology entrepreneur who has been involved in many top tier ventures, including two of Canada’s most successful biotech companies.

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), closed Wednesday's trading session at $0.4025, up 6.1165%, on 755,063 volume with 263 trades. The average volume for the last 3 months is 160,256 and the stock's 52-week low/high is $0.124389998/$0.522899985.

Recent News

chart

PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA)

The QualityStocks Daily Newsletter would like to spotlight PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA).

The truth is, there has been no better time to land a deal on a new car than now, according to a MarketWatch report (http://nnw.fm/60t1F), and PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) is there to facilitate any transaction safely and swiftly via its cloud-based auto trading platform, which can be used from smartphones and other digital devices, from any location. That’s good news in the social distancing brought on by the pandemic.

A Better Way to Connect and Acquire Vehicles

PowerBand’s mission is to create an online, consumer-directed marketplace that streamlines the interactions among all participants in the automotive industry. It transforms today’s antiquated business model with speed, transparency, access to information and ease of use for consumers and dealers.

Consumers can easily connect with new sources to buy vehicles, network with motivated buyers and sellers, maximize their trade-in values, improve their customer experience. PowerBand’s standardized system and transaction process also increase efficiencies and benefits with hands-on, process-driven, in-store training and support.

Through internal development, acquisitions, joint ventures and strategic partnerships, PowerBand is developing solutions for consumers, dealers, manufacturers, commercial customers and lenders that are poised to transform the trillion-dollar U.S. automotive industry.

The PowerBand Auto Platform

PowerBand’s transaction platform was developed by a team of experienced automotive, technology and finance experts, and has been refined through years of operational experience. Built on the core belief that the consumer prefers to primarily conduct automotive transactions online and avoid interactions with unnecessary middlemen, PowerBand’s product solutions include:

  • Leasing: PowerBand is currently licensed in 33 U.S. states via a majority interest in MUSA Auto Finance LLC, an advanced online leasing technology platform that has transformed the new and used vehicle leasing industry. A partnership with Tesla was recently finalized, making MUSA the only approved, non-captive lease partner for Tesla in the U.S.
  • Inventory and Financing: A partnership with RouteOne LLC, a leading financial platform founded in 2002 by Ally Financial, Ford Motor Credit Co., TD Auto Finance and Toyota Financial Services, allows access to a network of more than 18,000 dealerships and 1,400 financing sources.
  • Auction Platform: PowerBand and its joint-venture partner, D2D Auto Auctions, are developing a direct consumer-to-dealer and a consumer-to-consumer automotive portal, which will provide an innovative alternative to physical dealership and auction locations.
  • LiveNet Auction: An online platform portal that allows dealers to create instant live vehicle auctions to a vast network of the industry’s top used vehicle buyers.
  • MarketPlace Auction: An online listing auction site for buying and selling automotive inventory – ideal for dealers, fleet, OEM and rental companies.
  • Used Vehicle Inspections: An LOI agreement with TÜV NORD Mobility Inc., a German-based global leader in vehicle inspections operating in more than 70 countries, will provide the most comprehensive, certified vehicle inspection reports available in North America. Appointments booked within the platform can be performed nearly anywhere.
  • Product Development: PowerBand’s comprehensive consumer solution, Driveaway, will be a fully transactional consumer marketplace where dealers and consumers can buy, sell, trade-in and finance vehicles, often in seconds, from the comfort of their home.

Automotive’s Growing Markets

The automotive dealership and commercial fleet vehicle auction industry is a $100-billion sector with more than 40 million used vehicles transacted in the U.S. each year. Of those, ten million are sold through auctions. From 2013 to 2017, the growth of online-only auctions far outpaced physical auctions, growing at a 33% compound annual growth rate compared to 2% CAGR at physical auctions.

Automotive leasing is another large, growing and fragmented market, generating approximately $120-billion in annual revenue. As a percentage of vehicle sales, leasing reached 30% in 2018, up from 21% in 2012, and is seen as a substantial opportunity for PowerBand and MUSA Auto Finance. Using proprietary technology and by focusing on high-quality, credit-worthy customers, MUSA grew its automotive lease originations to $182 million.

Disrupting Auto Leasing with MUSA

Legacy solutions are complicated, expensive and slow at processing leases. MUSA’s first-of-its-kind technology platform eliminates third-party decisions and the human capital required in the underwriting process. MUSA’s platform navigates the entire customer experience – underwriting, funding and the delivery process – within minutes. Leases can be approved in seconds.

PowerBand’s acquisition of MUSA brings together two leading-edge companies with the vision to become a one-stop platform for the entire vehicle purchase lifecycle.

Experienced Leadership

PowerBand is led by a collection of automotive veterans with a passion to collectively and positively impact the industry.

  • Kelly Jennings, president and CEO, is the founder of PowerBand Solutions and a franchise dealer owner/operator with more than 27 years of automotive experience. Jennings received General Motor’s Triple Crown Award, Ford Motor Company President’s Award and Honda Canada’s Excellence Award.
  • Darrin Swenson, COO of PowerBand and D2D Auto Auctions/Hunt Automotive Group, has more than 25 years of automotive/auction experience.
  • Jeff Morgan, CEO MUSA, holds over 25 years of experience in the auto finance sector.

 

PowerBand Solutions Inc. (OTCQB: PWWBF), closed Wednesday's trading session at $0.09975, up 6.117%, on 143,400 volume with 4 trades. The average volume for the last 3 months is 35,706 and the stock's 52-week low/high is $0.038600001/$0.230000004.

Recent News

chart

National Storm Recovery Inc. (OTC: NSRI)

The QualityStocks Daily Newsletter would like to spotlight National Storm Recovery Inc. (NSRI).

National Storm Recovery (OTC: NSRI), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, recently acquired Mulch Manufacturing, a leader and innovator in the industry for more than three decades (http://nnw.fm/S0fTe). To view the full article, visit http://nnw.fm/WK2cC

National Storm Recovery Inc. (OTC: NSRI), through its subsidiaries, including National Storm Recovery, LLC (DBA Central Florida Arbor Care and Mulch Manufacturing, Inc.), provides tree services, debris hauling, removal and bio-mass recycling, manufacturing, packaging and sales of next-generation mulch products. The company’s primary corporate objective is to provide a solution for the treatment and handling of tree debris that is historically sent to local landfills and disposal sites, creating an environmental burden and pressure on disposal sites around the nation.

Environmentally Friendly

National Storm and the solutions provided by its Sustainable Green Team are founded in sustainability. The company’s vertically integrated operations begin with the collection of tree debris through its tree services division and collection sites. Tree bio-mass is then moved through the processing division for recycling and manufacturing into a variety of organic, attractive, next-generation mulch products to be packaged and sold to retailers, landscapers, installers and garden centers.

The company’s solutions create a synergistic and environmentally beneficial solution to tree and storm waste disposal that historically has created an environmental burden on landfills and disposal sites around the nation.

National Storm’s customers include governmental, residential and commercial customers and now big box retailers. The company is headquartered in Florida.

Strategic Acquisition

National Storm in February 2020 acquired 35-year-old industry leader and innovator Mulch Manufacturing, Inc., an Ohio corporation. Structured as a share exchange, this strategic partnership provides National Storm with a significantly larger footprint in the mulch industry.

The acquisition includes Mulch Manufacturing’s national and international distribution agreements, an increase in production and packaging capacity, and its sales contracts with numerous big box retailers. Mulch Manufacturing includes mulch production, sawmill operation, Natures Reflections colorant manufacturing and equipment manufacturing.

Next-Gen Products

National Storm’s vision and commitment to the environment is paired with Mulch Manufacturing’s revolutionary “next-generation” mulch product, Nature’s Reflection’s Softscape®.

Softscape mulch products, created from natural forest products, are color-enhanced with environmentally safe colorants to provide four-year color retention and are free from contaminants. Safe for people and pets, Softscape allows water and air to penetrate soil and roots, which is vital to plant health and growth.

Expansion Plans

National Storm plans to expand its operations through a combination of organic growth, through its partnership with a nationally recognized waste disposal company, and through strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified.

The company has received final zoning approval for its 100-acre site, located in Lake County, Astatula, Florida, which will serve as the company’s flagship tree debris collection site. The facility will also house the company’s mulch manufacturing, soil composting and production bagging. This prime location includes a 5,000-square-foot building that contains warehouse and office space. The 100-acre property can accommodate millions of cubic yards of organic debris and will allow National Storm’s debris hauling division to realize significant savings on its transportation costs.

National Storm has chosen as its new headquarters the Mulch Manufacturing 100,000-square-foot building in Jacksonville, Florida. The facility comprises centralized operations of Mulch Manufacturing, Inc. and National Storm Recovery, LLC, and has ample room to expand as the needed.

Leadership

National Storm’s Sustainable Green Team boasts more than 40 years of next-level experience with mulch manufacturing, treating and caring for trees. This team is guided by a roster of highly qualified professionals:

  • Tony Raynor, Chief Executive Officer
  • Edward Lee, Chief Operating Officer
  • Ralph Spencer, Director of Business Development, Strategic Acquisitions
  • Steve Ogden, ISA-Certified Arborist
  • Rick Starcher, Master Chemist
  • Peder K. Davisson, Esq., Corporate/Securities Counsel

National Storm Recovery Inc. (OTC: NSRI), closed Wednesday's trading session at $0.35, even for the day, on 2,300 volume with 3 trades. The average volume for the last 3 months is 964 and the stock's 52-week low/high is $0.05/$3.00.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioScience (OTCQB: PBIO) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries. On April 29, PBIO announced its entrance into a binding letter of intent to acquire Cannaworx Inc. (http://cnw.fm/6D1rT). To view the full article, visit http://cnw.fm/m9tyD

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Wednesday's trading session at $2.25, off by 4.2553%, on 20,915 volume with 40 trades. The average volume for the last 3 months is 15,196 and the stock's 52-week low/high is $0.600600004/$4.48999977.

Recent News

chart

Cannabis Global, Inc. (OTC: MCTC)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Global, Inc. (MCTC).

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, today announced that it has completed product development and has begun distribution of its unique tetrahydrocannabivarin (“THC-V”) coffee and tea products to product beta testers. According to the update, the company has integrated three internally developed technologies into the unique manufacturing process for the industry's first THC-V beverages. To view the full press release, visit http://cnw.fm/3CuQo. Also today, the company was highlighted in a publication from FinancialNewsMedia.com, examining the THC-V news in even greater detail.

Cannabis Global, Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

MCTC has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.

Cannabis Global, Inc. (MCTC), closed Wednesday's trading session at $0.458, up 30.8571%, on 107,007 volume with 133 trades. The average volume for the last 3 months is 33,723 and the stock's 52-week low/high is $0.05/$3.00.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium, certified-organic cannabis, on Tuesday announced its financial results for the first quarter of 2020 ended March 31, 2020. Among the highlights, the company reported a 27% year-over-year increase in revenue to $3.06 million and indicated that it is on track to reach its operational cash flow positive milestone. To view the full press release, visit http://cnw.fm/89JGc

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed Wednesday's trading session at $0.355, off by 11.25%, on 4,603,529 volume with 1,229 trades. The average volume for the last 3 months is 1,349,695 and the stock's 52-week low/high is $0.150000005/$3.00.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) was featured today in the 420 with CNW by CannabisNewsWire. Federal prohibition has been a massive thorn in the state legal marijuana industry’s side for years, and the coronavirus pandemic has made this abundantly clear. Despite cannabis being declared an essential service by most states with legal cannabis programs, businesses in the sector have been subject to federal restrictions that have made it nearly impossible to operate safely in these trying times. Aside from being denied access to relief funds dispensed by the federal government, marijuana businesses do not have access to the banking system, forcing them to operate on a cash only basis.

Supreme Cannabis Company Inc. (TSX: FIRE) (OTC: SPRWF) is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees and culture of innovation. The company aims to grow the world’s best legal cannabis and become a leader in the global industry. Supreme Cannabis calls its Toronto Venture Exchange stock symbol, “FIRE,” a testament to the company’s passion for cannabis and obsession with quality.

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as one of Canada’s most premium cannabis producers, the company sees itself at the center of this global shift.

A key piece of Supreme Cannabis’ ability to fulfill its mission is its flagship brand, 7ACRES, a wholly owned subsidiary that operates a 440,000-square-foot hybrid cultivation facility in Kincardine, Ontario. 7ACRES is focused on building a core competency in scaled high-quality cannabis production. With a best-in-class cultivation facility producing a competitive product that fuels a leading premium brand, Supreme Cannabis has achieved a differentiated advantage in cultivation IP, products and branding. The company’s foundational investment in premium cultivation has secured it a leadership position in the industry as the Canadian market becomes more competitive and matures.

Since legalization, 7ACRES has brought five premium flower strains to market in Canada. The demand for 7ACRES product continues with the company’s most recent launch of Jack Haze, a new proprietary premium cultivar. The company’s first sativa-dominant strain, Jack Haze offers rare sensory characteristics, delivering high THC content with a terpinolene forward profile, including a complex aroma with notes of citrus, pine and warm spice. As it develops its next winning strain, 7ACRES continues to prioritize subjective quality. In the Canadian cannabis market, this approach has established 7ACRES as a well-known premium brand that commands premium pricing coast-to-coast.

In addition to 7ACRES, Supreme Cannabis has built a diversified portfolio of focused consumer-driven brands:

  • Sugarleaf by 7AC – this new brand widens Supreme Cannabis’ product offerings and targets consumers who are looking for more refined, milder consumption experience as they discover their own cannabis taste preferences and desires. Product formats under this brand are focused on offering consumers elegant and convenient cannabis experiences.
  • Blissco — dedicated to providing wellness focused consumers with premium cannabis products, education, and outstanding customer care. Blissco is focused on bringing its collection of premium whole-flower CBD oils to market.
  • Truverra — focused on being a global leader in the development, production and marketing of hemp and cannabis-derived medicinal products with clinically proven efficacy. With over 25 SKUs sold online in the UK and Europe, Truverra is ideally positioned to address emerging international cannabis opportunities.
  • Khalifa Kush Enterprises — formed through a prestigious international partnership with Khalifa Kush Enterprises (KKE) Canada, the Canadian counterpart to the popular U.S. cannabis brand KKE formed by Wiz Khalifa. Together, Supreme Cannabis and KKE Canada are developing and launching a lineup of premium cannabis products, including a future line based on the well-known Khalifa Kush strain.

Each of Supreme Cannabs’ brands and partnerships have been strategically identified and designed to support the company’s mission to enhance the lives of consumers through positive cannabis experiences. Equally important to delivering desirable consumer experiences is the infrastructure supporting the company’s brands and products. From seed to sale, supreme cannabis continues to build an impressive group of operating assets that serve key functions throughout the value chain:

  • Cultivation – for starters, there is Supreme Cannabis’ foundational flagship asset, its 440,000-square-foot cultivation facility in Kincardine, Ontario. With over 600 employees, 24 grow rooms, and best-in-class processing equipment and procedures, this facility is expected to reach an annual production capacity of 50,000 kilograms in the near-term. In this purpose-built facility, the company grows small-batch high-quality cannabis from 10,000-square-foot grow rooms and completes a proprietary hang-dry for up to two weeks.
  • Extraction – with the acquisition of Blissco in fiscal 2019, in addition to the Blissco wellness brand, Supreme Cannabis gained a 12,000-square-foot dedicated extraction facility in Langley, BC. This facility conducts both C02 and ethanol extraction and with the recent receipt of its oil sales license from Health Canada, it now produces Blissco branded CBD oils and expects to fill vaporizer pods for a partnership between the company’s 7ACRES brand and Pax Labs.
  • Manufacturing – most recently, the company announced its 107,000-square-foot processing, packaging and manufacturing facility in Kitchener, naming the facility Supreme Cannabis Kitchener. In Q4 FY2020, the company expects to begin whole flower packaging and pre-roll manufacturing for Supreme Cannabis brands at the Kitchener Facility. In the long-term, in additional to processing its own inputs, Supreme Cannabis intends generate incremental revenue by packaging, distributing and branding third-party cannabis inputs from quality-focused cultivators.
  • R&D and Product Testing – In Q1 FY2020, Supreme Cannabis closed the acquisition of Truverra and acquired a 5,000-square-foot facility licensed under Canadian Clinical Cannabinoids Inc. in Scarborough, Ontario (“Supreme Cannabis Scarborough”). Supreme Cannabis Scarborough provides R&D space for the company to test new products and develop medicinal science intellectual property. In the near-term, with the legalization of 2.0 cannabis products, this centre for innovation will be testing and bringing concentrate products to market under the 7ACRES brand.

Supreme is committed to continue to identify new opportunities to grow and strengthen its impressive portfolio of operating assets and brands and scale its strong Canadian business globally.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Wednesday's trading session at $0.26, off by 4.3766%, on 884,006 volume with 406 trades. The average volume for the last 3 months is 622,859 and the stock's 52-week low/high is $0.101000003/$1.39999997.

Recent News

chart

Bolt Metals Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)

The QualityStocks Daily Newsletter would like to spotlight Bolt Metals Corp. (OTCQB: PCRCF).

Bolt Metals Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade battery metals deposits within the Asia-Pacific region, employing a vertically integrated “minerals-to-market” strategy to leverage these assets to their fullest.

Bolt Metals Corp. is advancing its flagship, 100% controlled Cyclops Nickel-Cobalt located in Papua Province, Indonesia with a mandate to become a key contributor to Asia-Pacific’s rapidly expanding electric vehicle and battery supply chain.

The Cyclops project, uniquely positioned within the world’s largest producer of nickel and in proximity to China, the world’s largest “Gigafactory”, features near surface, strong nickel-cobalt mineralization. The property is situated in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Bolt Metals well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.

Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to nickel-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.

Indonesia has recently approved environmental impact studies for factories to produce battery-grade nickel chemicals in Morowali. The approval will allow investors, such as China’s stainless steel giant Tsingshan Group, to continue the construction of their high-pressure acid leaching plants in Morowali, Central Sulawesi.

Ranjeet Sundher, chief executive officer of Bolt Metals, said: “Indonesia continues to make significant strategic decisions, and this latest announcement represents an important step in Bolt Metals’s efforts to benefit from Indonesia’s rapid development as a leading market for all stages of the EV supply chain. With offices in Vancouver, Shanghai and Jakarta, Bolt Metals is well positioned to leverage Asia’s global dominance in the battery manufacturing sector.”

Indonesia’s commitment extends to the very top of government, with Joko Widodo – Indonesia’s President – stating in September 2019 that “for nickel, we want raw materials to be processed in Indonesia. We want added values”. This supports previous pronouncements from key officials, including Indonesian Maritime Minister, Luhut Pandjaitan who remarked that Indonesia will “become the main player in lithium batteries” and that it will “control the world market”.

The country, which is the world’s top nickel ore exporter, has stopped export of unprocessed nickel ore to support this plan.

During 2019 the Company carried out an extensive exploration and development program on Cyclops and achieved successful nickel results with its drilling and bench-scale scoping tests for processing of materials.

Drilling identified significant horizons of nickel mineralization and bench-scale scoping tests returned positive results for processing of this nickel rich material.

The recovery percentages form the bench-scale test program are set out below (for further information, please refer to the Company’s press release of October 28, 2019):

Sample Nickel (%) Cobalt (%) Iron (%)
Limonite 99.26 98.82 97.77
Low Iron Transition 99.75 97.03 99.22
Saprolite 99.77 >99.9 99.74

 

Selected elevated nickel drill results are provided below from the Company’s shallow drilling program (for further information, please refer to the Company’s press releases of March 5, April 1, April 23, June 13, June 20 and September 10, 2019):

Intersection length (metres from surface) Nickel (%) Cobalt (%)
7.0 2.15% 0.03%
4.0 1.96% 0.04%
2.0 2.00% 0.01%
2.0 1.91% 0.05%

 

2020 will see continued and consistent development in Pacific Rim Cobalt’s strategy as the company continues to set ambitious milestones with the goal of becoming a leading international player in the EV battery metal sector and creating significant long-term shareholder value.

This includes preparations to commission and operate the company’s pilot plant in Canada, which will contain an integrated circuit to produce high-purity nickel and cobalt strip solutions to develop battery-grade nickel and cobalt.

The results of the pilot plant will then be used to establish the design criteria for the subsequent demonstration plant in Indonesia, which will produce nickel and cobalt products suitable to meet market specifications. As well as demonstrating Pacific Rim Cobalt’s ability to produce a product within market specifications, this will also be used to establish the design criteria for the company’s commercial-scale plant.

Pacific Rim Cobalt’s world-class management team includes Ranjeet Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.

Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.

Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.

Bolt Metals Corp. (OTCQB: PCRCF), closed Wednesday's trading session at $0.1174, up 9.7196%, on 4,724 volume with 6 trades. The average volume for the last 3 months is 42,863 and the stock's 52-week low/high is $0.079999998/$0.355599999.

Recent News

chart

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Wednesday's trading session at $1.62, off by 2.41%, on 590,246 volume with 1,452 trades. The average volume for the last 3 months is 1,027,996 and the stock's 52-week low/high is $0.05/$3.00.

Recent News

chart

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.

Proprietary Products

SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.

The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.

Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.

Global Network of Elepreneurs

Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.

SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”

Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.

In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.

Continued Momentum as Industry Leader

These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.

SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.

These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.

These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.

Preparing for Success

SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.

Contact
469.304.9400 x 201
Info@SHRGinc.com
http://www.SHRGinc.com

Sharing Services Global Corporation (SHRG), closed Wednesday's trading session at $0.07, even for the day, on 21,057 volume with 2 trades. The average volume for the last 3 months is 411,619 and the stock's 52-week low/high is $0.0215/$0.249799996.

Recent News

chart

Trxade Group Inc. (NASDAQ: MEDS)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (NASDAQ: MEDS).

Trxade Group Inc. (NASDAQ: MEDS) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade’s overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company’s pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, “E-Bay/Kayak-like” technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the “consumer side” of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called “Delivmeds” (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade’s Managed Services Organization (“TrxadeMSO”) enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient’s information, thereby ensuring appropriate medication coverage based on the patient’s location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade’s fair online market platform targets the nation’s retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE’s programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.  
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks (“PAC”) to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry. 
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE’s advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process. 

Management Team 

Trxade’s management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary
Suren Ajjarapu has served as Trxade’s chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer
Prashant Patel has served as Trxade’s full-time president and COO, and as a director since the company’s acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (MEDS), closed Wednesday's trading session at $5.60, off by 0.520491%, on 19,233 volume with 120 trades. The average volume for the last 3 months is 123,690 and the stock's 52-week low/high is $2.94000005/$11.6000003.

Recent News

chart

Champignon Brands Inc. (FWB: 496) (CSE: SHRM) (OTC: SHRMF)

The QualityStocks Daily Newsletter would like to spotlight Champignon Brands Inc. (CSE: SHRM).

Champignon Brands Inc. (FWB: 496) (CSE: SHRM) (OTC: SHRMF) is a research-driven company specializing in the formulation and distribution of a suite of artisanal mushroom health supplements. Dedicated to revolutionizing conventional organic teas, coffees and other consumables with the infusion of a proprietary blend of artisanal mushrooms, Champignon’s expanding portfolio is crafted with the health-conscious consumer in mind.

Headquartered in Vancouver, British Columbia, Champignon’s team aims to promote the health and wellness benefits of functional mushrooms, which are used in a wide variety of health care and pharmaceutical products.

Brands

Champignon’s mushroom-derived consumer packaged goods (CPGs) portfolio includes its flagship brand, Vitality Superteas. Each carefully curated Vitality Supertea formulation was developed with the intent of helping individuals enhance and enrich their wellbeing one cup of mushroom-infused tea at a time.

Also in the portfolio are Nourish Force Supertea, a blend of Reishi Ryobus Tea Mix; Mighty Recharge Supertea, created with Lions Mane Tropical Green Ginseng Tea Mix; and Brain Enhance Supertea, a blend of Cordycep Hibiscus and Berries Tea Mix – all of which are formulated with organic ingredients and chosen for their ability to provide unique health and performance benefits.

Champignon’s flagship e-commerce store, VitalitySuperTeas.com, takes advantage of the burgeoning craft mushroom vertical space with a selection of mushroom-infused teas and accessories.

Functional Mushroom Market

Demand for consumer products infused with the nutritional and bioactive benefits of mushrooms is fueling a global market projected to reach $34.3 billion by 2024, growing at a compound annual growth rate of 8.04% from 2019-2024 (ResearchandMarkets), with Europe seen as the fastest growth leader.

According to the market study, in highest demand are products infused with Reishi – a traditional Chinese medicine also known as the “Elixer of Life” and “Mushroom of Immortality – Lions Mane and Cordyceps, followed by other types of medicinal mushrooms.

Advances in Legalization

Legalization of psychedelics for use in medicine is gaining momentum across the United States. Denver, Colorado, and Oakland and Santa Cruz, California, have decriminalized the use of psilocybin, the psychedelic molecule found in various mushrooms, while movements for legalization are gaining ground in Oregon and Iowa, among others. Decriminalize California recently teamed up with the Beckley Foundation to replicate Oakland’s success of decriminalization throughout the state of California.

An increasing number of researchers are turning their attention toward the study of psilocybin as a means to treat otherwise untreatable illnesses. The molecule’s ability to provide landmark treatment options for depression, post-traumatic stress disorder (PTSD), migraines and addiction is gaining widespread acceptance among medical professionals, unicorn investors and accredited institutions.

Potential Applications

Historical data and new scientific studies suggest therapeutic benefits of psychedelics in many areas, including drug addiction, alcoholism, depression, migraines, smoking cessation and post-traumatic stress disorder (PTSD).

The market potential in these areas are significant. To reference just one of the above conditions, the mental health arena has been frequently neglected over the last 30 years, though new research is beginning to further reinforce that psychedelic compounds have the potential to produce more effective treatments than what is currently available.

According to the World Health Organization, 25% of the world’s populous will be afflicted by mental health and/or neurological disorders. Presently, approximately 450 million people currently suffer from such conditions, placing mental disorders among the leading causes of ill-health, productive loss and disability worldwide.

Additionally, PTSD affects approximately 2.2% of the U.S. population; 7.7 million people will have PTSD at some point in their lives. Recent published studies have demonstrated the safety and efficacy of certain psychedelics when administered in a medically supervised and monitored approach.
A renaissance in alternative medicines is emerging, and Champignon has set in motion its strategy to become a key player.

2020 Stealth IP Strategy

Champignon plans to biosynthesize psilocybin within the first three months of conducting laboratory experiments, with the objective of achieving optimized and scaled production of pharmaceutical-grade psilocybin for deployment in clinical settings. This strategy includes:

  • Alternative medicine (psilocybin) IP aggregation
  • Development of cGMP formulations of bioactive compounds extracted from plants and Fungi
  • Drafting of benchmark SOPs (Standard Operating Procedures)
  • Patient aggregation, focusing on veterans

Defining a New Asset Class: Psychedelic-Inspired Medicines

In the third quarter of 2020, Champignon – through clinical trials, a compelling IP portfolio and clinical pipeline and drug development platform – plans to advance its pursuit of treatments underpinned by psychedelic substances. This strategy is broken down into two ties:

  • Non-Hallucinogenic Medicines
    • Microdosing Psilocybin/LSD
    • MDMA, commonly known as ecstasy
  • Hallucinogenic Medicines
    • Psilocybin high dose
    • LSD high dose

Partnerships

Companies worldwide are beginning to incorporate functional mushrooms into their product offerings, taking advantage of growing consumer awareness of known health benefits of the ingredients found in mushrooms.

Champignon in November 2019 entered into a distribution partnership with Eurolife Brands Inc. (CSE: EURO), a leading global markets cannabis brand empowering the medical, recreational and CPG cannabis industry worldwide through a data-driven CBD marketplace supported by exclusive and unbiased physician-backed cannabis education and detailed consumer analytics. Under the agreement, Champignon’s branded products are integrated into Eurolife’s e-commerce platform, along with potential distribution opportunities in select brick-and-mortar retail locations in Europe.

Champignon also has an R&D/production formulation agreement with Drip Coffee Social Ltd., located in Nanaimo, British Columbia, which calls for the infusion of Champignon’s proprietary mushroom extract blend into a suite of cold brew coffee products and signature in-house formulations.

Leadership

Gareth Birdsall, CEO, Corporate Secretary and Director
Gareth Birdsall has more than seven years of experience working in diverse agricultural roles such as the cultivation of various fungi, in particular Cordycepes, Reishi, Lions Mane and Chaga. He is an attendee of the British Columbia Institute of Technology, studying marketing management and finance.

Steven Brohman, CPA, CFO
Steven Brohman has more than 10 years of experience working in a variety of roles with public and private companies. He has had extensive training in the audit of publicly traded companies on the TXS, TSX Venture Exchange and OTC markets, and serves as CFO and director of various public and private companies. Brohman has a bachelor’s degree of business administration and obtained his Chartered Professional Accountant designation.

Jerry Habuda, Director
Jerry Habuda brings to Champignon over 35 years of expertise in law enforcement and specialized units. From 1977 to 2012, he served as a police officer with the Toronto Police Department. During his tenure, he was assigned to the Major Crimes Unit, investigating robberies and home invasions. He was assigned to patrol the Toronto Community Housing projects at Jane/Finch to control drug trafficking and gun violence. Habuda was with the Warrant Unit where he tracked down and arrested wanted criminals. From 1993-1997, he was assigned to the Northwest Drug Squad on undercover and surveillance work, executing narcotic search warrants. Between 2002 and 2004, Habuda headed the Street Violence Task Force, a special unit designed to curb gun and drug violence that was terrorizing the city at the time.

Champignon Brands Inc. (CSE: SHRMF), closed Wednesday's trading session at $1.30, off by 2.2556%, on 564,863 volume with 689 trades. The average volume for the last 3 months is 622,395 and the stock's 52-week low/high is $0.221/$1.74.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.